Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:sildenafil
|
| gptkbp:approvalYear |
1998
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
gptkb:G04BE03
|
| gptkbp:chemicalFormula |
C22H30N6O4S
|
| gptkbp:contraindication |
nitrate medication
|
| gptkbp:discoveredBy |
gptkb:Pfizer
|
| gptkbp:eliminationHalfLife |
4 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
VIGRA
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Pfizer
|
| gptkbp:marketedIn |
gptkb:Europe
gptkb:India gptkb:United_States |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
headache
dyspepsia flushing visual disturbances |
| gptkbp:tradeNameOf |
sildenafil citrate
|
| gptkbp:usedFor |
erectile dysfunction
|
| gptkbp:bfsParent |
gptkb:Eigen_(C++_library)
|
| gptkbp:bfsLayer |
8
|